Overview
GSK is a British health-care company that researches, develops and manufactures medicines and vaccines, organised into Commercial Operations and Research and Development segments; Commercial Operations has three product groups: specialty medicines, vaccines and general medicines.[2] Forbes records sales of US$43.9bn, up 9.6% on the prior-year figure, profit of US$7.8bn and a market value of US$99.2bn.[2] GSK holds thirteenth place, as in the prior-year comparison. Haleon, a consumer-health company also based in the United Kingdom, is listed separately by Forbes with sales of US$14.5bn and is not included in GSK’s figures.[2] GSK and AstraZeneca are the two UK companies in the top 25. Forbes counts 66,841 employees.[2]
GSK plc strengths and limitations
Strengths
- Large vaccines business
- Profit margin of about 18%
- Sales growth of 9.6%
Limitations
- Market value below US$100bn
- General medicines face generic competition
- Smaller than AstraZeneca on every Forbes metric
Appears in
GSK plc peers and competitors
Companies ranked in the same lists as GSK plc.
AstraZeneca PLC
Shell plc- Amgen
Merck & Co.
Pfizer- AbbVie
Novartis
Bayer AG
Novo Nordisk
Sanofi- Bristol Myers Squibb
Gilead Sciences
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.